首頁 > 儀器試劑 > Reagent 試劑 > Agilent > NGS 相關 > ClearSeq Cardiomyopathy

ClearSeq Cardiomyopathy

ClearSeq 心肌相關病變基因研究


ClearSeq Cardiomyopathy is a next generation sequencing target enrichment panel designed specifically for inherited forms of cardiomyopathy. Following a careful review of cardiomyopathy publications as well as information available from GeneReviews, an NIH online resource, 34 genes known to be associated with hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrythmogenic right ventricular cardiomyopathy have been included.Compatible with HaloPlexHS and HaloPlex Target Enrichment Systems

ClearSeq Cancer

Designed specifically for inherited forms of cardiomyopathy including hypertrophic, dilated and rightCompatible with HaloPlexHS and HaloPlex

產品列表

貨號 產品 數量
G9943A ClearSeq Cardiomyopathy, HS, ILM 16 rxns
G9943B ClearSeq Cardiomyopathy, HS, ILM 96 rxns
G9908A ClearSeq Cardiomyopathy, ILM 16 rxns
G9908B ClearSeq Cardiomyopathy, ILM 96 rxns
G9944A ClearSeq Cardiomyopathy, HS, ION 16 rxns
G9944B ClearSeq Cardiomyopathy, HS, ION 96 rxns
G9909A ClearSeq Cardiomyopathy, ION 16 rxns
G9909B ClearSeq Cardiomyopathy, ION 96 rxns

ClearSeq Cardiomyopathy

  • Expert-optimized content - Highly targeted content enabling analysis of regions implicated in rare disease pathogenesis
  • Fast track to answers - Proven, high-performing capture oligos are coupled with highly efficient SureSelect and HaloPlex workflows, providing faster time to results and compatibility with samples of limited availability (high throughput or benchtop sequencers)
  • Comprehensive Workflow Solution - Accelerated sample to categorized variants with SureCall
回到頂端